Introduction {#sec1}
============

Over the past few years, convincing evidence has demonstrated that several amyloid-dependent disorders can be transmitted by a prion-like mechanism.^[@ref1],[@ref2]^ Cellular and animal models of diverse neurodegenerative disorders have implicated α-synuclein, amyloid-β (Aβ), tau, and polyQ mutant Huntingtin (mHTT) among others as being able to seed their associated pathologies.^[@ref3]−[@ref6]^ For example, a pathological form of α-synuclein in glial cytoplasmic inclusion (GCI-α-Syn), which is conformationally and biologically distinct from that in Lewy bodies (LB-α-Syn), maintains a high seeding propensity in neurons and results in multisystem atrophy.^[@ref7],[@ref8]^ Furthermore, prion-like seeding as a mechanism for the pathological spread in Alzheimer's disease (AD) and tauopathy has been demonstrated, as has the ability of mHTT to participate in seed conversion and spread via cell-to-cell transfer.^[@ref9]−[@ref15]^

The mechanism by which amyloids nucleate their soluble monomeric counterparts (homotypes), and the processes driving their interneuronal spread, has been well established. Yet, the pathways by which these prion-like particles engage amyloid proteins differing in sequence (heterotypes) in different cells have only recently been investigated.^[@ref16]−[@ref20]^ Results indicate that in addition to its prion-like disruption of the monomeric status of proteins such as α-Syn and PDI, Aβ (25--35) (a truncated variant of Aβ that reproduces the cardinal phenotypes associated with AD) insult to cells results in elevated levels of reactive oxygen (ROS) and nitrogen species (RNS). Furthermore, Aβ (25--35) insult results in the chemical modification of PDI catalytic thiols, upregulation of cellular housekeeping machinery, and increased ubiquitination of misfolded debris.^[@ref5]^ The results from the model cell line studies suggest that Aβ (25--35) contributes to cross-toxic outcomes via (at least) two different pathways.^[@ref21]^

As stated before, what is less clear is how much this seed-spread mechanism eventually contributes to, and drives, "heterotoxicity", a process by which a pathogenic seed infiltrates a non-native cellular milieu, corrupts cellular processes therein, and initiates a seemingly unrelated neurodegenerative cascade.^[@ref22]^ However, this notion is not new. There already exists evidence that appears to indicate potential in these self-templating vectors to "cross-fertilize" unrelated neuropathies, at times, in neuronal regions distinct from their point of origin. For example, in AD, Aβ aggregates have been found to be copathological with TDP-43 cytoplasmic inclusions (over 50% of the cases) and with α-Syn Lewy neurites and LBs (over 40% of cases).^[@ref23]^ Conversely, α-Syn pathology in Lewy bodies has been found to co-occur with Aβ pathology (\>80% of the cases), with NFT and NT at Braak stage \> II (over 50% of cases) and with TDP-43 pathology (over 30% overlap).^[@ref24]−[@ref28]^

Brazilin ((6*aS*,11*bR*)-7,11*b*-dihydro-6*H-*indeno\[2,1-*c*\]chromene-3,6*a*,9,10-tetrol) from *Caesalpinia sappan* is an established antioxidant.^[@ref29],[@ref30]^ Brazilin, as a phenolic antioxidant, has a potent inhibitory effect against Aβ (25--35) neurotoxicity. Here, we examine its role in preventing amyloid-β (Aβ)-induced toxicity, aggregation, and in modulating the Aβ-dependent aggregation pathway of other amyloid proteins.

Results and Discussion {#sec2}
======================

Dynamic Light Scattering (DLS) {#sec2.1}
------------------------------

[Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} depicts the size of Aβ (25--35) in solution measured using dynamic light scattering. In accord with previous studies, Aβ (25--35) was found to be (1.0--1.5 nm) below concentrations of 100 μM, beyond which it was found to form aggregates ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref31],[@ref32]^

![Size of the Aβ oligomer preparation. This graph depicts the presence of the oligomeric size distribution intensity with a diameter of ∼1.0--1.5 nm (the two small peaks to the left), whereas the third peak of the graph (to the right) corresponds to the formation of protofibrils.](ao0c00396_0001){#fig1}

1,1-Diphenyl-2-picrylhydrazyl (DPPH) Assay {#sec2.2}
------------------------------------------

For the specific antioxidant activity of Brazilin, we tested the in vitro radical scavenging ability of Brazilin measured by the diminution in the UV absorbance maximum of the DPPH radical. Brazilin in DMSO at concentrations 2.5 and 5 μM was able to quench the DPPH radical absorbance, suggesting that, at both concentrations, the antioxidant was capable of reducing the reactive oxygen species stress ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). The percentage of DPPH radical inhibition was found to be 65.7% at 2.5 μM and 79.5% at 5 μM, using ascorbic acid as a reference.^[@ref33]^

![Brazilin radical scavenging activity. The graph shows free radical scavenging activity at 2.5 and 5.0 μM. Both concentrations were able to decrease the absorbance obtained from the free radical solution, 1,1-diphenyl-2-picrylhydrazyl (DPPH).](ao0c00396_0002){#fig2}

Cytotoxicity of Brazilin, Aβ (25--35), and Cotreatment {#sec2.3}
------------------------------------------------------

The cytotoxicity profile of Brazilin (1% v/v DMSO) in the cell line was established by measuring the percentage of cell death as a function of Brazilin ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). Utilizing the unbiased dose--response graph, concentrations that were found not to be cytotoxic to the SH-SY5Y cell line were used for further experiments. There was no difference between "untreated" vehicle control and Brazilin treatment on SH-SY5Y cells up to a concentration of 5 μM Brazilin. Aβ (25--35) cytotoxicity was also independently evaluated at 24 h after the introduction into the cells. The results reveal a smooth, dose-dependent increase in cytotoxicity ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}B--D demonstrates how cell morphology is altered as a function of Aβ (25--35). Clear changes in morphology are observed between 10 and 35 μM of the added peptide, 24 h after incubation ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}C,D).^[@ref34]^ Also, the results suggest that Brazilin is able to protect cells from the cytotoxic effects of Aβ (25--35) ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). The results indicate that the protective effects of Brazilin are observed only at a concentration of 5 μM across the concentration range of Aβ (25--35) tested (0--5 μM).

![Brazilin dose--response curve using SH-SY5Y cells after 24 h of exposure. Panel (A) shows the cytotoxicity effect at different concentrations of Brazilin. (B, C) Result of DMSO and H~2~O~2~ as the positive and negative controls, respectively, to assess Brazilin cytotoxicity. Data are mean values ± SD; differences were established using Student's *t*-test.](ao0c00396_0003){#fig3}

![Identification of amyloid-β (25--35) effect after 24 h. (A) Cytotoxicity of Aβ (25--35) at different concentrations after 24 h of treatment. (B--D) Cell morphology changes in bright-field cell images of the SH-SY5Y cell line after 24 h of treatment of Aβ (25--35). Images were captured by using live-cell microscopy, as indicated in images; each of the scale bars represents 20 μM distances. Data are mean values ± SD; differences were established with Student's *t*-test compared to those of the vehicle group.](ao0c00396_0004){#fig4}

![Brazilin (Braz) rescues amyloid-β (25--35) toxicity. Cytotoxicity of Brazilin showing its protective effect against Aβ (25--35) insult at different concentrations after 24 h of treatment. Data are mean values ± SD; differences were established with Student's *t*-test compared to those of the vehicle group.](ao0c00396_0005){#fig5}

Defining the Role of Brazilin in the Interaction of α-Synuclein and PDI Aggregation Induced by Aβ (25--35) {#sec2.4}
----------------------------------------------------------------------------------------------------------

Aβ (25--35) is known to disrupt cellular homeostasis and the solubility status of proteins. These include α-Syn, synphilin-1 (Synp-1), and PDI.^[@ref35],[@ref36]^ We determined whether Brazilin was able to maintain homeostasis under Aβ (25--35) insult. The addition of 20 μM Aβ (25--35) resulted in an increased expression of the housekeeping oxidoreductase chaperone compared to that of the untreated and vehicle controls as a result of cellular stress ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). By contrast, results indicate that SH-SY5Y cells treated with Brazilin (2.5 and 5 μM) for 1 h followed by the addition of Aβ (25--35) and subsequent incubation for 24 h attenuated the impact of the peptide on PDI expression levels; i.e., the presence of Brazilin (2.5 and 5 μM) caused a reduction of aggregate expression levels when compared with that of the 20 μM Aβ (25--35) insult. Both concentrations of applied Brazilin had statistically significant impacts ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}A).

![PDI and α-synuclein overexpression in SH-SY5Y cells. (A, B) SH-SY5Y neuroblastoma cells were fixed after 24 h of exposure with Aβ (25--35) toxicity and Brazilin (2.5 and 5 μM). After 1 h of prophylactic treatment, Aβ (25--35) at 20 μM was added and incubated for 24 h at 37 °C. Immunocytochemistry was then performed for the detection of PDI and α-Syn levels; the fluorescence intensity of 10 ROI's was determined for calculation. (C--H) Confocal microscopy images reveal the presence of aggregates in the cell (yellow). All treatments were immunostained with DAPI to label the nucleus (blue color), protein disulfide isomerase (PDI) antibody with Alexa-488 (green color), and α-synuclein antibody with Texas Red (red color). Graphs show the mean intensity quantification of PDI (A) and α-Syn (B) in the cell upon treatment. Data are mean values ± SD; differences were established with Student's *t*-test, with *P*-value. All images were obtained in a confocal microscope 20× objective; scale bar measures 20 μM and is quantified using LSM Zeiss software (Zen 2009).](ao0c00396_0006){#fig6}

As previously reported, Aβ (25--35) upregulated the levels of α-Syn in SH-SY5Y cells ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}B). However, unlike with PDI, the presence of Brazilin does not attenuate the α-Syn level at the tested concentrations of the polyphenol.

Impact of Brazilin against Aβ (25--35)-Induced Apoptosis {#sec2.5}
--------------------------------------------------------

Aβ (25--35) insult to SH-SY5Y precipitates apoptosis.^[@ref37],[@ref38]^ We examined whether Brazilin at 2.5 and 5.0 μM conferred neuroprotection by mitigating cellular apoptosis and necrosis. The bars in [Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"} represent untreated cells; cells treated with DMSO (1% v/v); cells treated with Brazilin at 2.5 μM; Brazilin at 2.5 μM + Aβ 50 μM; Brazilin at 5.0 μM; Brazilin at 5.0 μM + Aβ 50 μM and Aβ 50 μM; and H~2~O~2~ 100 μM. Note that we observed batch-to-batch differences in the cytotoxic potential of Aβ. Hence, here we used Aβ (25−35) 50 μM instead of 20 μM used previously. However, the presence of appropriate controls serves to account for differences in concentrations used. Green bars represent the total percentage of apoptotic cells, which is expressed as the sum of the lower-right quadrant (early apoptosis) and the top-right quadrant (late apoptosis) ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}A). Cells positive to PI and negative to Annexin V-FITC are represented as red bars, and they are defined as the necrotic cell subpopulation.

![Flow cytometry analysis of Brazilin at different concentrations against the apoptosis induced by Aβ (25--35). Cells were double-stained with PI and Annexin V-FITC and then analyzed by flow cytometry. The bar graph panel in (A) shows the death pathway on SH-SY5Y induced by Aβ (25--35) in 50 μM. 7(B--I) Histograms of untreated cells, vehicle, 100 μM H~2~O~2~, 50 μM Aβ, and Brazilin treatment for 24 h; each bar represents a triplicate measurement, and error bars represent the mean values ± SD; differences were established with Student's *t*-test with a *P*-value \<0.05.](ao0c00396_0007){#fig7}

The results indicate that 50 μM of Aβ (25--35) induces apoptosis (high statistical significance was found when the DMSO control, 50 μM of Aβ (25--35), and 2.5 μM Braz + Aβ (25--35) treatment conditions were compared). Brazilin at both 2.5 and 5.0 μM was able to rescue the cells from 50 μM of Aβ (25--35)-induced apoptotic cell death. Cells treated with 100 μM of H~2~O~2~ were used as the positive control, in which an increase in early, late apoptosis, and necrosis was demonstrated.

Fluorescence Inhibition of Lysozyme Fibrillation {#sec2.6}
------------------------------------------------

We tested whether Brazilin can directly inhibit protein fibrillization. Lysozyme was used as a model fibril-forming protein.^[@ref39]^ Fibril presence was assessed by Thioflavin T (ThT). In [Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}, the fluorescence intensity of the control (lysozyme fibrils alone) is greater than when Brazilin was introduced at the start of the lysozyme fibril-forming process. The reduction in the fluorescence intensity suggests that Brazilin (5 μM) functions as a prophylactic and can mitigate the formation of amyloid-like fibrils in proteins.

![ThT fluorescence inhibition of the lysozyme aggregation by Brazilin 5 μM.](ao0c00396_0008){#fig8}

Conclusions {#sec3}
===========

The presence of distinct biomarkers in AD and PD have led to their historical qualification as two different neurodegenerative disorders. Yet, cross-toxicity has been reported, whereby one amyloid protein associated with a particular neuropathy can trigger a seemingly unrelated pathology.^[@ref16]−[@ref21]^ In this study, we demonstrate that cross-pathology induced by Aβ (25--35) can be mitigated by Brazilin, a natural polyphenolic compound extracted from *C. sappan*.^[@ref29],[@ref30]^ Our results reveal that the polyphenol can reduce reactive oxygen species, protect cells from Aβ toxicity, maintain cellular homeostasis, and inhibit protein aggregation of amyloidogenic proteins. The standard DPPH assay confirmed Brazilin as a potent antioxidant that can scavenge free radicals. Using hen egg-white lysozyme, a model amyloid fibril-forming protein as an exemplar, ThT fluorescence assays established the inhibitory effect of Brazilin on its amyloid-forming trajectory. Additionally, cell viability assays reveal that Brazilin was able to maintain cell homeostasis when co-incubated with Aβ (25--35), which was found to increase the expression of oxidoreductase chaperone and enhance cellular stress. Brazilin not only protected cultured cells from formation of aggregates but also mitigated the cellular apoptotic and necrotic death. Finally, the approach investigated in this study will help develop a comprehensive understanding of the cross-toxic origins promoted by amyloidogenic proteins. This work is not only a stepping stone to furthering our understanding of the players involved in cross-pathologies but provides a platform with which to test prophylactics that may eventually advance/improve therapeutic outcomes.

Methods {#sec4}
=======

Chemicals, Cell Line, and Reagents {#sec4.1}
----------------------------------

The following reagents were sourced commercially and used without further purification. Brazilin, propidium iodide (PI), and hexafluoroisopropanol (HFIP) (MP Biomedicals 154862, 19548); human Aβ 25--35 (Ana Spec AS-24448); Annexin V kit containing Annexin V-FITC and PI (Beckman Coulter); 1,1-diphenyl-2-picryl-hydrazyl (DPPH; Millipore-Sigma USA); Hoechst 33342 (Life Technology H1399); trypsin-EDTA 0.25% (Life Technologies, 25200-056); protein disulfide isomerase (PDI) antibody, and α-synuclein (Cell Signaling Technology; C81H6, 2647). Most of the secondary antibodies were obtained from Abcam (Alexa Fluor 488, Texas red; ab150077, ab6787), and Fluoro-Gel II Mounting Medium was obtained from Fisher Scientific 17985-50. Lysozyme (CAS:12650-88-3) and Thioflavin T (CAS 2390-54-7) were purchased from Sigma-Aldrich.

Cell Culture {#sec4.2}
------------

Human neuroblastoma cells (SH-SY5Y) (ATCC, Manassas, VA) were grown in a culture medium (DMEM/F-12, 398225 SIGMA) and supplemented with 10% fetal bovine serum. Prophylactically, 1% v/v of penicillin/streptomycin (15-140-122; Gibco) was added to the medium. Cells were maintained by incubation at 37 °C with 5% carbon dioxide. All experiments were performed by seeding the cells into 96-, 24-, 12-, and 6-well plates. Once confluent, the cells were then pretreated with Brazilin (2.5 and 5.0 μM) for 1 h, followed by Aβ (25--35) addition (20, 50 μM) and incubated for 24 h.

Preparation of Aβ 25--35 {#sec4.3}
------------------------

Briefly, human Aβ (25−35) was dissolved in HFIP, aliquoted, and incubated at room temperature for at least 30 min.^[@ref40]^ The HFIP was allowed to evaporate, and the aliquots were stored at −20 °C. Immediately prior to use, Aβ (25--35) was dissolved in DMSO.^[@ref38]^ The size (monomer, oligomer, fibril) of Aβ (25--35) in solution was periodically measured using dynamic light scattering (DLS), as previously described.^[@ref29],[@ref30],[@ref41]^

Radical Scavenging Activity by DPPH Method {#sec4.4}
------------------------------------------

The 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay was performed as previously described.^[@ref42]^ Briefly, 2 mM of DPPH was freshly prepared in methanol prior to use; Brazilin stock was prepared in DMSO and diluted. Solutions were incubated for 5 min, and then spectrophotometric measurements were obtained at 517 nm. The percentage of free radical inhibition was calculated by using the following formula^[@ref43],[@ref44]^

Cytotoxicity Assay {#sec4.5}
------------------

The cytotoxic potential was assayed by seeding ≥10 000 cells/well into a 96-well plate format. Consistently, the plates were incubated at 37 °C with 5% carbon dioxide with Braz (2.5 and 5.0 μM) and Aβ (25--35). Propidium iodide (PI) and Hoechst, at a final concentration of 1 μg/mL each, were added to each well 1 h prior to obtaining readings. Images were acquired in a live-cell mode using a multiwell plate reader (IN-Cell 2000 automated microscopy system; GE Healthcare) equipped with a 10× objective and an IN-cell analyzer 2000 acquisition v4.0 software (GE Healthcare).^[@ref45],[@ref46]^ Four contiguous fields with a montage of 2 × 2 were acquired per well and per fluorescence channel. Image capture and data analysis were translated to an IN-Cell analyzer workstation v3.7.2 software (GE Healthcare), which was used to realize data segmentation of the images (thus providing the region of interest and the cytotoxicity percentages of cell death per each well). Each of the experiments was repeated eight times.^[@ref47]^

Immunofluorescence and Protein Colocalization {#sec4.6}
---------------------------------------------

After cells were pretreated for 24 h with Brazilin prior to Aβ (25--35) exposure, they were washed with PBST (phosphate-buffered saline + 0.1% v/v Tween-20 detergent) and fixed with 4% paraformaldehyde in PBS. Cells were then incubated with a blocking solution (5% normal goat serum (NGS) and 5% of FBS fetal bovine serum in PBS with 0.1% TWEEN-20) for 1 h on the shaker to eliminate unspecific binding of the antibodies. After three repeated washes, cells were incubated with primary antibody overnight at 4 °C diluted in 3% BSA in PBST. The secondary antibody, conjugated with an Alexa Flour tag, 488, and Texas Red (goat antimouse, antirabbit, and DAPI), was added for 2 h at room temperature on the shaker. Images were captured using an LSM 700 confocal microscope, assisted with Zen 2009 software (Zeiss). For consistency, images were acquired at a 512-pixel resolution by utilizing a 488 nm laser with a laser power of 5.0, speed 7, averaging 8 and 1.0 Airy Units (AUs). Besides, no further adjustments were applied in brightness, contrast, or gamma settings.^[@ref41],[@ref48]^

Flow Cytometric Detection of Apoptotic and Necrosis Cells {#sec4.7}
---------------------------------------------------------

To discern between apoptosis versus necrosis pathways, cells seeded in a 24-well plate were harvested, washed with cold PBS, and centrifuged. Then, cell pellets were gently resuspended by using 100 μL of the binding buffer added with Annexin V-FITC and PI reagents following the manufacturer's instructions (Beckman Coulter). Subsequently, cells were incubated for 15 min on ice while protected from light, followed by the addition of ice-cold binding buffer to the suspension. The mixture prepared according to the manufacturer's instructions (Beckman Coulter) was gently homogenized and immediately analyzed via flow cytometry (Gallios, Beckman Coulter) using the FL1 and FL2 detectors. The percentage of apoptotic cells is defined as the sum of both early and late stages of apoptosis, Annexin V-FITC positive. For each sample, approximately 10 000 events (cells) were collected and analyzed by using Kaluza software (Beckman Coulter).^[@ref49],[@ref50]^

Fluorescence Inhibition of Lysozyme Fibrillation {#sec4.8}
------------------------------------------------

Lysozyme aggregates were prepared by dissolving 139 μM (2 mg/mL) of lysozyme in 20 mM KH~2~PO~4~ with 3 M guanidine hydrochloride at a pH of 6.3, for a total volume of 1.8 mL, as previously described.^[@ref51],[@ref52]^ Brazilin was prepared as previously mentioned, dissolved in DMSO at a concentration of 5 μM, and added to its respective vials. Vials were incubated for 5 h at 60 °C at a constant agitation of 500 rpm. After 5 h, the formation of fibrils was observed. Samples were added to a Quartz cuvette, followed by the addition of 20 μM ThT and measured using a DM45 Spectrofluorimeter (On-Line Instrument System, Inc.). A 2 min scan was performed at a constant integration time (0.1 s) using an excitation and emission monochromator at 450 and 482 nm, respectively. All measurements were performed in triplicate ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

###### Summary of Compounds and Concentrations Used

  figures   compound                                 concentration                                           experiment
  --------- ---------------------------------------- ------------------------------------------------------- -------------------------
  1         amyloid-β                                100 mM                                                  DLS analysis
  2         Brazilin                                 5 μM, 2.5 μM                                            DPPH analysis
  3         Brazilin, DMSO, H~2~O~2~                 0.1, 1, 2.5, 5, 7.5, 12.5, 25, 50, 100 μM, 2%, 100 μM   cytotoxicity
  4         amyloid-β, DMSO, H~2~O~2~                1, 5, 10, 20, 25, 30, 35, 50, 2%, 100 μM                cytotoxicity
  5         Brazilin and amyloid-β, DMSO, H~2~O~2~   0.1, 1, 2.5, 5 μM, 20 μM, 2%, H~2~O~2~                  cytotoxicity
  6         Brazilin and amyloid-β, DMSO, H~2~O~2~   0.1, 1, 2.5, 5 μM, 20 μM, 2%, H~2~O~2~                  immunocytochemistry
  7         Brazilin and amyloid-β, DMSO, H~2~O~2~   2.5, 5 μM, 50 μM, 2%, H~2~O~2~                          apoptosis assay
  8         Brazilin and lysozyme                    5 μM, 2 mg/mL                                           fluorescence inhibition

Statistical Analysis {#sec4.9}
--------------------

All data were obtained in replicates to demonstrate the experimental viability and variability between samples; therefore, data presents the average with the corresponding standard deviation ± SD. Statistical analysis was performed by using a two-tailed paired Student's *t*-test to demonstrate the statistical significance of variances between the samples and controls. To identify significant differences between groups, a *P*-value was calculated.
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